Pure Global

Dry powder inhaler - ARTG 353640

Access comprehensive regulatory information for Dry powder inhaler in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is registered under ARTG number 353640 and sponsored by Viatris Pty Ltd, manufactured by Mylan Pharmaceuticals Inc in United States of America. The device registration started on January 27, 2021.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class I
ARTG 353640
Class I
Dry powder inhaler
ARTG ID: 353640
Good Name: Viatris Pty Ltd - Dry powder inhaler
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

The T-326 Dry Powder Inhaler is a hand-held, manually operated, passive device intended to be used for pulmonary delivery of dry powder drugs. The T-326 Inhaler is intended to be used for different drug products and by the target population specific to the drug products.

Device Classification
Risk Class
Class I
Product Type
Procedure Pack
ARTG Category
General
Registration Information
ARTG ID
353640
Start Date
January 27, 2021
Effective Date
January 27, 2021
Sponsor
Manufacturer
Country
United States of America
Address
150 Industrial Road, San Carlos, California, 94070